(redirected from Platelet-activating factor)
Also found in: Dictionary, Thesaurus, Medical, Financial, Encyclopedia, Wikipedia.
Related to Platelet-activating factor: platelet-activating factor (PAF)


An event, circumstance, influence, or element that plays a part in bringing about a result.

A factor in a case contributes to its causation or outcome. In the area of Negligence law, the factors, or chain of causation, are important in determining whether liability ensues from a particular action done by the defendant.

West's Encyclopedia of American Law, edition 2. Copyright 2008 The Gale Group, Inc. All rights reserved.


n. 1) a salesman who sells in his/her own name on behalf of others, taking a commission for services. 2) something that contributes to the result.

Copyright © 1981-2005 by Gerald N. Hill and Kathleen T. Hill. All Right reserved.


1 a mercantile agent. An agent who is in the ordinary course of business entrusted with goods or documents of title representing goods with a view to their sale. A factor has a lien over goods entrusted to him; this lien covers any claims he may have against his principal arising out of the agency. Most factors will be mercantile agents (and have the powers of such) for the purposes of the Factors Act 1889. Under this Act, in certain circumstances a factor may pass a good title to goods entrusted to him.
2 an institution to whom a company assigns its book debts (see FACTORING).
3 in Scotland a landlord or superior's agent.
Collins Dictionary of Law © W.J. Stewart, 2006
References in periodicals archive ?
[3] Nonstandard abbreviations: Lp-[PLA.sub.2], lipoprotein-associated phospholipase 2; FDA, Food and Drug Administration; MS, mass spectrometry; SISCAPA, stable isotope standards and capture by anti-peptide antibody; FA, formic acid; PAF, Platelet-activating factor; MRM, multiple reaction monitoring; LOQ, limit of quantification; SDS, sodium dodecyl sulfate; apoB, apolipoprotein B; LDL-C, low-density lipoprotein cholesterol; LDL-p, low-density lipoprotein particle number; HDL-C, high-density lipoprotein cholesterol; HDL-p, high-density lipoprotein particle number.
Barletta et al., "Synthesis of platelet-activating factor (PAF) in transformed cell lines of a different origin," Prostaglandins & Other Lipid Mediators, vol.
Bazan, "Distinct platelet-activating factor binding sites in synaptic endings and in intracellular membranes of rat cerebral cortex," The Journal of Biological Chemistry, vol.
Olson, "Platelet-activating factor: receptors and signal transduction," Biochemical Journal, vol.
Eberhardt et al., "Anti-inflammatory properties of a platelet-activating factor acetylhydrolase," Nature, vol.
Platelet-activating factor (PAF) has been studied by Porras-Reyes and Mustoe as a chemotactic agent with no cell proliferative properties [36].
The neuroprotective properties of the Ginkgo biloba leaf: a review of the possible relationship to platelet-activating factor (PAF).
Human serum paraoxonase (aryldialkylphosphatase, EC; PON1) and human serum platelet-activating factor acetylhydrolase (1-alkyl-2-acetyl-glycero-phosphocholine esterase, 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine acetohydrolase, EC; PAF-AH) are associated with HDL [1, 2].
The hemoSTATUS[R] (Medtronic Blood Management) test is designed to assess the effects of platelet-activating factor (PAF) in shortening the kaolin ACT in whole blood [120,130].

Full browser ?